T 0304/17 (Antibody that binds IL-17A/F and inhibits induction of IL-8 and IL-6/GENENTECH) of 10.01.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T030417.20200110
- Date of decision
- 10 January 2020
- Case number
- T 0304/17
- Petition for review of
- -
- Application number
- 04754234.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- IL-17 A/F heterologous polypeptides and therapeutic uses thereof
- Applicant name
- Genentech, Inc.
- Opponent name
- Ablynx N.V.
Merck Patent GmbH
Novartis AG
Janssen Biotech, Inc.
Adams, Harvey Vaughan John
Eli Lilly and Company (intervener I)
Eli Lilly Nederland B.V. (intervener II) - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 105(1)(a) (2007)European Patent Convention Art 105(1)(b) (2007)European Patent Convention Art 105(2) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention R 89(1) (2007)
- Keywords
- Intervention of the assumed infringer - admissible (yes)
Main request, auxiliary requests 1 to 3: amendments - allowable (no) - Catchword
- -
- Citing cases
- T 1809/22
Order
For these reasons it is decided that:
The appeal is dismissed.